kaonavi
4435
D. Western Therapeutics Institute
4576
Itamiarts
168A
Nakayo
6715
Allied Telesis Holdings KK
6835
(Q3)Dec 31, 2024 | (Q2)Sep 30, 2024 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||||||
Cash from operating activities | 15.42%17.23B | -71.54%5.72B | -4.30%16.19B | 39.90%64.92B | 48.24%12.99B | -27.59%14.92B | 405.08%20.09B | 29.56%16.92B | 33.17%46.41B | 30.53%8.76B |
Net profit before non-cash adjustment | 53.07%6.74B | 117.17%6.01B | -8.52%6.42B | -39.85%15.74B | 173.98%1.56B | -45.26%4.4B | -69.64%2.77B | -36.89%7.02B | -22.27%26.18B | -134.12%-2.1B |
Total adjustment of non-cash items | 13.88%6B | -52.06%3.59B | 31.44%10.2B | 24.05%34.38B | 39.50%13.86B | -33.36%5.27B | 67.80%7.49B | 43.43%7.76B | 7.59%27.71B | -11.30%9.94B |
-Depreciation and amortization | -0.51%7.77B | -2.39%7.92B | -0.08%7.91B | 8.67%31.85B | 12.08%8.01B | 5.40%7.81B | 10.58%8.12B | 6.76%7.92B | 1.51%29.31B | -2.58%7.15B |
-Reversal of impairment losses recognized in profit and loss | ---- | ---- | ---- | 131.79%3.6B | ---- | ---- | ---- | ---- | 170.26%1.55B | ---- |
-Share of associates | -9,100.00%-1.35B | -9,790.91%-1.07B | -274.29%-671M | 149.77%958M | 126.97%547M | 103.58%15M | 102.15%11M | 131.17%385M | 42.74%-1.93B | 163.09%241M |
-Disposal profit | --0 | 88.24%-2M | 99.84%-2M | -7,140.91%-1.59B | -29,300.00%-294M | -1,000.00%-22M | -21.43%-17M | -25,100.00%-1.26B | 95.62%-22M | -133.33%-1M |
-Other non-cash items | 80.02%-507M | -424.24%-3.27B | 311.23%2.97B | 63.16%-445M | 100.50%2B | -378.29%-2.54B | 73.51%-623M | 194.50%721M | -814.79%-1.21B | -72.89%995M |
Changes in working capital | -14.60%4.49B | -139.42%-3.88B | -120.05%-429M | 297.97%14.8B | -361.53%-2.43B | 12.70%5.25B | 202.52%9.84B | 161.62%2.14B | 69.58%-7.48B | 108.71%928M |
-Change in receivables | -389.41%-6.75B | 3,134.14%10.04B | -446.07%-4.76B | -51.31%3.59B | -97.64%214M | -33.12%2.33B | 53.90%-331M | 130.82%1.37B | 138.78%7.37B | 1,374.26%9.06B |
-Change in inventory | -7.87%-1.43B | -119.48%-1.05B | 1,084.96%2.68B | 155.19%4.93B | -86.55%646M | 60.67%-1.32B | 230.08%5.38B | 103.62%226M | 43.33%-8.93B | 441.36%4.8B |
-Provision for loans, leases and other losses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 162.50%50M | ---- | ---- |
-Changes in other current assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -78.57%-25M | ---- | ---- |
-Changes in other current liabilities | ---- | -367.26%-12.87B | 220.00%1.65B | 206.18%6.29B | 75.21%-3.24B | -7.59%4.2B | 202.34%4.82B | -92.96%515M | -157.89%-5.92B | -54.73%-13.07B |
Dividends paid (cash flow from operating activities) | ||||||||||
Dividends received (cash flow from operating activities) | ||||||||||
Interest paid (cash flow from operating activities) | 30.58%-193M | 17.64%-467M | 3.21%-241M | -278.41%-1.72B | -252.54%-624M | -112.21%-278M | -912.50%-567M | -176.67%-249M | -33.53%-454M | -71.84%-177M |
Interest received (cash flow from operating activities) | -7.51%825M | 43.87%446M | -11.68%1.33B | -42.34%3.11B | 13.13%405M | -1.55%892M | 5.44%310M | -60.79%1.51B | 94.63%5.4B | 18.15%358M |
Tax refund paid | 53.74%-1.37B | 243.43%829M | 79.62%-832M | 14.81%-8.44B | -41.42%-816M | -17.76%-2.96B | 75.56%-578M | 8.23%-4.08B | -345.26%-9.91B | -125.39%-577M |
Other operating cash inflow (outflow) | -166.67%-2M | 250.00%3M | -2M | 200.00%1M | 0 | 3M | 33.33%-2M | 0 | 0.00%-1M | 0.00%1M |
Operating cash flow | 31.06%16.48B | -66.09%6.53B | 16.69%16.45B | 39.65%57.88B | 42.86%11.95B | -33.34%12.58B | 941.94%19.26B | 13.99%14.1B | 18.22%41.45B | 25.67%8.37B |
Investing cash flow | ||||||||||
Net PPE purchase and sale | -162.49%-14.21B | -85.66%-5.68B | -33.38%-6.43B | 19.53%-17.16B | 6.76%-3.86B | 5.84%-5.41B | 42.89%-3.06B | 20.59%-4.82B | -9.57%-21.32B | 2.66%-4.14B |
Net intangibles purchase and sale | -43.24%-318M | 21.65%-398M | 54.55%-170M | 1.05%-1.42B | 2.48%-314M | 49.43%-222M | -46.82%-508M | -14.72%-374M | 30.67%-1.43B | 41.88%-322M |
Net business purchase and sale | ---- | ---- | ---- | 85.62%-570M | ---- | ---- | ---- | ---- | -692.60%-3.96B | ---- |
Net investment product transactions | -11.59%61M | 940.87%2.62B | 5,565.38%1.42B | 562.10%2.9B | 504.41%2.61B | 134.33%69M | --252M | -112.50%-26M | -47.36%438M | 471.55%431M |
Net changes in other investments | -230.88%-784M | 63.73%650M | 161.11%385M | 84.82%560M | 119.70%194M | 4,707.69%599M | -59.45%397M | -295.65%-630M | 115.43%303M | -0.41%-985M |
Investing cash flow | -207.00%-15.25B | 3.84%-2.81B | 18.07%-4.79B | 39.62%-15.68B | 78.33%-1.95B | 22.41%-4.97B | 38.23%-2.92B | 0.27%-5.85B | -12.17%-25.98B | -52.07%-8.98B |
Financing cash flow | ||||||||||
Net issuance payments of debt | 689.29%12.66B | 76.14%-1.36B | 27.94%-3.79B | -269.44%-15.06B | 76.66%-1.98B | -135.15%-2.15B | -1,179.47%-5.68B | -134.84%-5.26B | -17.83%-4.08B | -47.06%-8.48B |
Net common stock issuance | 77.42%-894M | -136,800.00%-4.11B | 0.00%-1M | -31.89%-3.97B | 99.71%-3M | -99.65%-3.96B | -50.00%-3M | 50.00%-1M | -60,040.00%-3.01B | -101,900.00%-1.02B |
Increase or decrease of lease financing | -4.90%-407M | -5.23%-443M | 14.52%-412M | 14.03%-1.81B | 13.55%-523M | 37.12%-388M | -3.19%-421M | -0.42%-482M | -10.70%-2.11B | -1.34%-605M |
Cash dividends paid | -131.94%-8.21B | --0 | 1.67%-3.48B | 6.71%-7.07B | --0 | 1.56%-3.54B | --0 | 11.36%-3.53B | -52.11%-7.58B | --0 |
Cash dividends for minorities | ---233M | --0 | -68.51%-760M | 21.02%-451M | --0 | --0 | --0 | 21.02%-451M | -44.19%-571M | --0 |
Net other fund-raising expenses | ---- | ---- | ---- | -96.00%1M | ---- | ---- | --0 | 200.00%1M | --25M | --40M |
Financing cash flow | 129.07%2.92B | 3.23%-5.91B | 13.24%-8.44B | -63.75%-28.36B | 75.12%-2.5B | -10,244.33%-10.03B | -5,360.34%-6.1B | -33.59%-9.73B | -61.11%-17.32B | -58.15%-10.06B |
Net cash flow | ||||||||||
Beginning cash position | 10.57%55.02B | 54.08%60B | 41.23%55.13B | -0.83%39.04B | -6.15%46.38B | 27.73%49.76B | -4.21%38.94B | -0.83%39.04B | 8.32%39.36B | 12.90%49.42B |
Current changes in cash | 271.09%4.15B | -121.33%-2.18B | 317.65%3.22B | 847.68%13.83B | 170.29%7.5B | -119.61%-2.43B | 470.36%10.23B | -89.62%-1.48B | -261.01%-1.85B | -90.30%-10.67B |
Effect of exchange rate changes | 343.20%2.33B | -576.79%-2.79B | 19.10%1.65B | 48.69%2.26B | 325.51%1.25B | 49.95%-956M | -45.44%586M | -33.04%1.38B | -18.70%1.52B | -75.52%294M |
Cash adjustments other than cash changes | ---- | ---- | --1M | ---1M | ---- | ---- | ---- | ---- | ---- | ---- |
End cash Position | 32.59%61.49B | 10.57%55.02B | 54.08%60B | 41.23%55.13B | 41.23%55.13B | -6.15%46.38B | 27.73%49.76B | -4.21%38.94B | -0.83%39.04B | -0.83%39.04B |
Free cash flow | -71.86%1.95B | -97.15%447M | 28.16%9.84B | 103.21%37.31B | 96.10%7.05B | -45.45%6.92B | 504.57%15.67B | 28.77%7.68B | 43.43%18.36B | 94.06%3.59B |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |